Search

Author/Creator Subklewe, M.

1. Arming T cells with C-X-C-motive receptor 6 enables adoptive T cell therapy of pancreatic cancer. (March 2019)

Authors:
Lesch, S.; Blumenberg, V.; Stoiber, S.; Ogonek, J.; Cadilha, B.; Dantes, Z.; Rataj, F.; Dorman, K.; Lutz, J.; Karches, C.; Heise, C.; Grassmann, S.; Megens, R.; Ruehland, S.; Di Pilato, M.; Pruessmann, J.; Ormanns, S.; Reischer, A.; Duewell, P.; Schnurr, M.
Journal:
European journal of cancer
Issue:
Volume 110(2019)Supplement 1
Page Start:
S25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. EXTRANODAL DISEASE IS ASSOCIATED WITH SHORTER PROGRESSION‐FREE SURVIVAL AFTER CD19‐CAR T‐CELL THERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (17th June 2021)

Authors:
Bücklein, V.; Blumenberg, V.; Ackermann, J.; Frölich, L.; Winkelmann, M.; Schmidt, C.; Rejeski, K.; Ruzicka, M.; Müller, N.; von Baumgarten, L.; Schöberl, F.; Hildebrandt, M.; Humpe, A.; Kunz, W.; Hoster, E.; von Bergwelt, M.; Subklewe, M.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P1438: PROCALCITONIN IS ELEVATED IN SEVERE INFECTIONS AFTER CD19 CAR-T IN R/R B-NHL AND ENABLES DISCRIMINATION OF EARLY INFECTIONS FROM CRS – PARTICULARLY IN COMBINATION WITH THE CAR-HEMATOTOX SCORE. (23rd June 2022)

Authors:
Rejeski, K.; Blumenberg, V.; Hildebrand, F.; Frölich, L.; Karschnia, P.; Dreyling, M.; von Bergwelt-Baildon, M.; Schmidt, C.; Subklewe, M.; Bücklein, V.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P1445: MYTCELL®: AN INTERACTIVE SMARTPHONE APPLICATION FOR CARS AND BITES INCREASES GUIDELINE ACCESSIBILITY AND REDUCES TIME TO APPLY EVIDENCE-BASED PATIENT CARE. (23rd June 2022)

Authors:
Blumenberg, V.; Siegmund, L.; Frölich, L.; Rejeski, K.; Warm, M.; Hildebrand, F.; Schmidt, C.; von Bergwelt, M.; Bücklein, V.; Subklewe, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1328
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE. (23rd June 2022)

Authors:
Bücklein, V.; Perez, A.; Iacoboni, G.; Rejeski, K.; Holtick, U.; Penack, O.; Kharboutli, S.; Blumenberg, V.; Ackermann, J.; Frölich, L.; Johnson, G.; Patel, K.; Arciola, B.; Schmidt, C.; Albanyan, O.; Gödel, P.; Hoster, E.; Bullinger, L.; Mackensen, A.; Locke, F.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1330
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT SURVIVAL OUTCOMES AFTER CD19-DIRECTED CAR T-CELL THERAPY FOR R/R LBCL. (23rd June 2022)

Authors:
Rejeski, K.; Albanyan, O.; Iacoboni, G.; Bücklein, V.; Blumenberg, V.; Penack, O.; Bethge, W.; Völkl, S.; Perez, A.; Carpio, C.; Schmidt, C.; Müller, N.; Reid, K.; Faramand, R.; Davila, M.; Bullinger, L.; Locke, F.; von Bergwelt-Baildon, M.; Mackensen, A.; Barba, P.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1340
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P356: SUBGROUP ANALYSES OF KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL) IN ZUMA-3. (23rd June 2022)

Authors:
Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; O'Dwyer, K. M.; Arellano, M. L.; Lin, Y.; Baer, M. R.; Schiller, G. J.; Subklewe, M.; Abedi, M.; Minnema, M. C.; Wierda, W. G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
256
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P433: ADAPTER HOLIDAYS MAINTAIN IN-VITRO ADCAR-T CELL FUNCTIONALITY AGAINST AML. (23rd June 2022)

Authors:
Nixdorf, D.; Sponheimer, M.; Berghammer, D.; Zieger, N.; Rohrbacher, L.; Dapa, S.; Seitz, C. M.; Brandstetter, K.; von Bergwelt-Baildon, M.; Leonhardt, H.; Mittelstaet, J.; Kaiser, A.; Bücklein, V.; Subklewe, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
333
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT. (23rd June 2022)

Authors:
Frölich, L.; Blumenberg, V.; Rejeski, K.; Schmidt, C.; Winkelmann, M.; Schöberl, F.; von Baumgarten, L.; Kunz, W.; Bücklein, V.; Subklewe, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
2080
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗